Detalles de la búsqueda
1.
Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent.
Catheter Cardiovasc Interv
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713843
2.
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials.
Neth Heart J
; 32(6): 254-261, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776038
3.
Short-Term Outcomes of Elective High-Risk PCI with Extracorporeal Membrane Oxygenation Support: A Single-Centre Registry.
J Interv Cardiol
; 2022: 7245384, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36189196
4.
Using real-world data to monitor and improve quality of care in coronary artery disease: results from the Netherlands Heart Registration.
Neth Heart J
; 30(12): 546-556, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389133
5.
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Cardiovasc Diabetol
; 20(1): 217, 2021 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717627
6.
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
Catheter Cardiovasc Interv
; 98(2): E188-E196, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33694294
7.
First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial.
Circ J
; 85(11): 1983-1990, 2021 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261828
8.
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Am Heart J
; 228: 109-115, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882569
9.
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.
Catheter Cardiovasc Interv
; 96(5): E508-E515, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237060
10.
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial.
Lancet
; 392(10154): 1235-1245, 2018 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253879
11.
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial.
Am Heart J
; 198: 25-32, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653644
12.
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
Cardiovasc Drugs Ther
; 32(6): 567-576, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143879
13.
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
Lancet
; 388(10060): 2607-2617, 2016 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806902
14.
Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial.
Cardiology
; 137(4): 207-217, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28445871
15.
Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial.
Am Heart J
; 176: 28-35, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27264217
16.
Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II).
Am Heart J
; 175: 121-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179731
17.
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
Lancet
; 383(9915): 413-23, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24183564
18.
Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): rationale and study design of the randomized TWENTE III multicenter trial.
Am Heart J
; 167(4): 445-51, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24655691
19.
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents.
Eur Heart J Acute Cardiovasc Care
; 12(11): 774-781, 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37619976
20.
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention.
Front Cardiovasc Med
; 10: 1160201, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37745109